|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net Sales | |||||
| Cost of products sold | |||||
| Gross Profit | |||||
| Research and development | |||||
| Selling and general expenses | |||||
| Goodwill and intangibles impairment | |||||
| Other (income) expense, net | |||||
| Operating (Loss) Income | |||||
| Interest income | |||||
| Interest expense | |||||
| Loss Before Income Taxes | |||||
| Income tax (provision) benefit | |||||
| Loss from Continuing Operations | |||||
| Loss from discontinued operations, net of tax | |||||
| Net Loss | |||||
| Loss Per Share | |||||
| Basic: | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Basic Loss Per Share (in dollars per share) | |||||
| Diluted: | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Diluted Loss Per Share (in dollars per share) |
Loading...
